• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用激动剂-拮抗剂相互作用的无偏模型进行药理实验的设计。

The design of pharmacological experiments using unbiased models of agonist-antagonist interaction.

作者信息

Vere D W

出版信息

J Pharmacol Exp Ther. 1978 Jun;205(3):617-23.

PMID:660533
Abstract

The methods which exist to represent agonist-antagonist interactions, and to distinguish between them are sufficient and effective. Their effective use depends on a set of criteria which are not always fulfilled in actual experiments. In some situations it is difficult or impossible to meet these criteria. An alternative representation is proposed, using straightforward geometry, which evades this problem. It also allows experimental data points to be selected without bias and makes it possible to apply orthodox criteria to more restricted sets of data than is otherwise the case. To do this, it is necessary to reverse the ordinary procedure in antagonist assays, by adding successive concentrations of antagonist to a preparation so that a constant response is evoked by squared multiples of the original agonist dose. This can only be done with rapidly reversible antagonists, but the method has been shown to be effective for such drugs.

摘要

现有的表示激动剂 - 拮抗剂相互作用并区分它们的方法是充分且有效的。它们的有效使用取决于一组标准,而这些标准在实际实验中并非总能得到满足。在某些情况下,很难或不可能满足这些标准。本文提出了一种使用直观几何图形的替代表示方法,该方法避免了这个问题。它还允许无偏差地选择实验数据点,并使得能够将正统标准应用于比其他情况更受限的数据组。为此,有必要颠倒拮抗剂测定中的常规程序,即向制剂中逐次添加拮抗剂浓度,以便通过原始激动剂剂量的平方倍数引发恒定反应。这只能用快速可逆的拮抗剂来完成,但该方法已被证明对这类药物有效。

相似文献

1
The design of pharmacological experiments using unbiased models of agonist-antagonist interaction.使用激动剂-拮抗剂相互作用的无偏模型进行药理实验的设计。
J Pharmacol Exp Ther. 1978 Jun;205(3):617-23.
2
Developments of computer-based estimation of pA2 values and associated analysis.基于计算机的pA2值估计及相关分析的进展。
J Pharmacol Exp Ther. 1978 Dec;207(3):705-18.
3
Antagonist inhibition curves and the measurement of dissociation constants.拮抗剂抑制曲线和解离常数的测定。
Br J Pharmacol. 1997 Jan;120(1):13-8. doi: 10.1038/sj.bjp.0700865.
4
Rational design of receptor partial agonists and possible mechanisms of receptor partial activation: a theory.受体部分激动剂的合理设计及受体部分激活的可能机制:一种理论
J Theor Biol. 1996 Aug 7;181(3):273-91. doi: 10.1006/jtbi.1996.0130.
5
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
6
Synergistic combinations of anticonvulsant agents: what is the evidence from animal experiments?抗惊厥药物的协同组合:来自动物实验的证据有哪些?
Epilepsia. 2007 Mar;48(3):412-34. doi: 10.1111/j.1528-1167.2006.00952.x.
7
Modification of dose-response curves by effector blockade and uncompetitive antagonism.效应器阻断和非竞争性拮抗作用对剂量-反应曲线的影响。
Mol Pharmacol. 1982 Sep;22(2):369-80.
8
[The methodology for researching the combined action of pharmacological substances by using the mathematical theory of experiments].[运用实验数学理论研究药理物质联合作用的方法]
Eksp Klin Farmakol. 1993 Nov-Dec;56(6):59-62.
9
Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology.定量药理学或药代动力学-药效学整合应成为整合药理学的重要组成部分。
J Pharmacol Exp Ther. 2009 Dec;331(3):767-74. doi: 10.1124/jpet.109.157172. Epub 2009 Sep 24.
10
Principles of pharmacodynamics and their applications in veterinary pharmacology.药效学原理及其在兽医药理学中的应用。
J Vet Pharmacol Ther. 2004 Dec;27(6):397-414. doi: 10.1111/j.1365-2885.2004.00620.x.